Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial

Objectives: To evaluate the efficacy and safety of lurasidone in the treatment of children and adolescents with bipolar depression presenting with mixed (subsyndromal hypomanic) features. Methods: Patients, 10–17 years of age, with a Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DS...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Child Adolesc Psychopharmacol
Egile Nagusiak: Singh, Manpreet K., Pikalov, Andrei, Siu, Cynthia, Tocco, Michael, Loebel, Antony
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Mary Ann Liebert, Inc., publishers 2020
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7757594/
https://ncbi.nlm.nih.gov/pubmed/32392455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2020.0018
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak